Epic Sciences Gets $15M In Credit Facility

San Diego-based Epic Sciences,, a developer of diagnostics products aimed at treating and managing cancer, has expanded a credit facility it has from Silicon Valley Bank from $5M to $15M. Terms and rates on that credit facility were not announced. The company said the additional capital will give it the option to accelerate its research capability and product development. Epic Sciences is developing technology for characterizing circulating tumor cells (CTCs) in cancer, which can be used to better hone cancer treatment and detect signs of drug resistance.